Showing 101 - 120 results of 1,877 for search 'harm is (((((resolves. OR removeddsddds.) OR resolves.) OR revolvesd.) OR involved.) OR involves.)', Forespørselstid: 0.44s Refine Results
  1. 101
  2. 102
  3. 103
  4. 104
  5. 105

    Trends in the valuation of injury involving the face: an analysis on trial in Rio Grande do Sul, Brazil af Gabriela Cauduro da ROSA (4647883)

    Udgivet 2020
    “...To measure the damage, the assessment of the bodily harm is required. Objective To analyze jurisprudential characteristics involving the valuation of the damage related to facial trauma, highlighting trends Methods It was analyzed secondary data, which are public domain, of the precedents of the Court of Justice of Rio Grande do Sul State from 2008 to 2016. ...”
  6. 106
  7. 107
  8. 108

    Table_3_Early Response to the Plant Toxin Stenodactylin in Acute Myeloid Leukemia Cells Involves Inflammatory and Apoptotic Signaling.xlsx af Daniele Mercatelli (6031271)

    Udgivet 2020
    “...<p>Stenodactylin, a highly toxic type 2 ribosome-inactivating protein purified from the caudex of Adenia stenodactyla Harms, is a potential anticancer drug candidate. ...”
  9. 109

    Table_1_Early Response to the Plant Toxin Stenodactylin in Acute Myeloid Leukemia Cells Involves Inflammatory and Apoptotic Signaling.xlsx af Daniele Mercatelli (6031271)

    Udgivet 2020
    “...<p>Stenodactylin, a highly toxic type 2 ribosome-inactivating protein purified from the caudex of Adenia stenodactyla Harms, is a potential anticancer drug candidate. ...”
  10. 110

    Table_2_Early Response to the Plant Toxin Stenodactylin in Acute Myeloid Leukemia Cells Involves Inflammatory and Apoptotic Signaling.xlsx af Daniele Mercatelli (6031271)

    Udgivet 2020
    “...<p>Stenodactylin, a highly toxic type 2 ribosome-inactivating protein purified from the caudex of Adenia stenodactyla Harms, is a potential anticancer drug candidate. ...”
  11. 111
  12. 112

    Patient Involvement in Preparing Clinical Research Peer-Reviewed Publications or Results Summaries: A Systematic Review af Karen L. Woolley (4910764)

    Udgivet 2018
    “...<div><b>Objective</b></div><div>Although patient involvement in results reporting is being encouraged, relevant evidence must be assessed before developing best practice guidelines. ...”
  13. 113
  14. 114
  15. 115
  16. 116
  17. 117
  18. 118
  19. 119
  20. 120